about
Helus Pharma Inc, the commercial operating name of Cybin Inc, is a clinical-stage pharmaceutical company focused on developing proprietary neuroactive compounds, referred to as NSAs, which are synthetic molecules designed to target serotonin pathways...
Read More
12.61
0.02
(0.16%)
805.5K
XNAS Volume
XNAS 25 Sep, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
Helus Pharma Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..